[Chemoembolization of hepatocellular carcinoma in cases of isolated liver involvement].
Chemoembolization is an effective treatment for hepatocellular carcinoma, giving results equally as good as surgical therapy for T2 tumours. Survival can be prolonged and side-effects can be reduced by combining Lipiodol and Gelfoam for chemoembolization, employing a modified technique, with repeated procedures, and using appropriate follow-up treatment. The toxicity of the procedure is acceptable, but it requires supportive therapy necessitating an intense interdisciplinary co-operation.
Galanski
M
M
Abteilung Diagnostische Radiologie I, Medizinische Hochschule Hannover.
Schmoll
E
E
Reichelt
S
S
Böhmer
G
G
Prokop
M
M
Schaefer
C
C
Schüler
A
A
Ringe
B
B
Schmidt
F W
FW
Schmoll
H J
HJ
D000368:Aged; D006528:Carcinoma, Hepatocellular / Q000453:epidemiology / Q000628:therapy*; D016461:Chemoembolization, Therapeutic; D015251:Epirubicin / Q000008:administration & dosage*; D005260:Female; D005860:Germany, West / Q000453:epidemiology; D006801:Humans; D008113:Liver Neoplasms / Q000453:epidemiology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies
D015251:Epirubicin
Chemoembolisation hepatozellulärer Karzinome bei isoliertem Leberbefall.